US Investment Saving Lives Around the World
April 27, 2012
U.S. funding has driven development of new vaccines and medicines.
A new report says the U.S. government is the world leader when it comes to investing in global health research and development. Over the past 10 years, the U.S. has provided nearly 13 billion dollars for new vaccines, drugs and equipment to fight diseases in developing countries.
The report is called
Saving Lives and Creating Impact: Why investing in global health research works.
It focuses on five federal agencies between 2000 and 2010: The National Institutes of Health, USAID, the Department of Defense, Centers for Disease Control and Prevention, and the Food and Drug Administration.
“The global Health Technologies Coalition is a group of nearly 40 nonprofits that have all come together to address some of the greatest barriers facing the development of new vaccines, new drugs, new diagnostics and other products. And looking at the policy solutions that the U.S. government can apply in order to accelerate and advance the development of those critically needed new products,” said Kaitlin Christenson, director of The Global Health Technologies Coalition, which released the report.
The coalition is funded by the Bill and Melinda Gates Foundation.
Having an effect
Christenson said U.S. investment in global health is having a “true impact” on the developing world.
最新
2013-11-25
2013-11-25
2013-11-25
2013-11-25
2013-11-25
2013-11-25